Our NEOs are also eligible for benefits upon termination of service in the event of change in control (“CIC”) as described in the “Compensation and Benefits Assurance Agreements” discussion in the next section.
Standard Severance Program for Ms. Hooper
As a vice president, Ms. Hooper is not eligible for benefits under the Executive Severance Plan, however she is eligible for severance benefits under the Company’s standard severance program for management and staff. The plan provides that in the event of an involuntary termination without Cause, vice presidents may receive two weeks cash severance per year of service up to a maximum of 52 weeks; and if enrolled in the Company’s medical plans at the time of termination, cash severance to assist with COBRA premiums, equal to a fixed amount for every 4 weeks of severance.
Severance Arrangement with Dr. Blankenship and Mr. Rudolph
The Committee approved severance benefits payable to Dr. Blankenship and Mr. Rudolph in connection with their separation from service with the Company in January and March 2020, respectively, which consisted of a cash payment and COBRA-related payment, as described in the “Potential Payments on Termination of Employment or Change in Control” section. The Committee determined these severance benefits were appropriate given the circumstances of Dr. Blankenship and Mr. Rudolph’s separation in connection with the Company’s restructuring activities following our completed sale of Qdoba Restaurant Corporation and related events. Both Dr. Blankenship and Mr. Rudolph qualified as retirement eligible under the Company’s equity and qualified retirement plans.
Retention, Transition and Separation Agreement (“Transition Agreement”) for Mr. Comma
In April 2020, the Company entered into a Transition Agreement with Mr. Comma, Former CEO, to support the successful transition to the incoming CEO, Mr. Harris, and to designate the terms of Mr. Comma’s employment through his separation date with the Company, including (a) performing his regular duties as CEO until the start date of the incoming CEO, and (b) for up to ninety (90) days thereafter, provide certain transition services in a non-executive and non-officer capacity (the “Transition Period”), with a resulting change in base salary at the annualized rate of $700,000. The additional benefits, provided under the Transition Agreement, and prorated through the duration of the Transition Period included:
• | An annual incentive payment under the Company’s performance incentive program for fiscal 2020, based on attainment level of performance goals; and |
• | Vesting of the final tranche of unvested restricted stock units remaining under his November 2015 restricted stock unit award, which were scheduled to vest in November 2020, subject to a six-month delay pursuant to 409A regulations from his date of separation of employment. |
Retention Agreement (“Retention Agreement”) for Mr. Tucker
In April 2020, the Company entered into a Retention Agreement with Mr. Tucker, Former CFO, to help enable a smooth transition in connection with Mr. Harris joining the Company. The agreement provided that in exchange for Mr. Tucker’s continued employment with the Company through December 31, 2020 he would receive retention benefits that included a lump sum cash payment of $610,000 (equal to his annual base salary) and a release from the obligation to pay relocation expenses related to his relocation to San Diego in 2018; and, in the event of employment through December 31, 2020 and such payment and release of obligation was made, Mr. Tucker’s December 2019 retention RSU award would be cancelled and forfeited and he would cease to be eligible for any benefits under the Executive Severance plan until July 1, 2020. Subsequently, Mr. Tucker announced his resignation in July 2020 and separated his employment with the Company in September 2020. Mr. Tucker’s Retention Agreement was null and void on his separation date and no benefits were earned or paid to Mr. Tucker.
In addition to the Executive Severance Plan, and the Transition Agreement for Mr. Comma, the 2020 NEOs have executed change in control (“CIC”) agreements that provide for benefits upon termination of service in the event of CIC as described in the “Compensation and Benefits Assurance Agreements” discussion in the next section.
The severance benefits payable to Dr. Blankenship and Mr. Rudolph in connection with their separation from service with the Company in January and March 2020, respectively, and reported in our 2020 proxy statement, are described in the “Potential Payments on Termination of Employment or Change in Control” section.